Next Article in Journal
Laboratory- and Pilot-Scale Cultivation of Tetraselmis striata to Produce Valuable Metabolic Compounds
Next Article in Special Issue
Impact of Chorionic Somatomammotropin In Vivo RNA Interference Phenotype on Uteroplacental Expression of the IGF Axis
Previous Article in Journal
Spectroscopic Detection of Biosignatures in Natural Ice Samples as a Proxy for Icy Moons
 
 
Communication
Peer-Review Record

The Histopathological “Placentitis Triad” Is Specific for SARS-CoV-2 Infection, and Its Acute Presentation Can Be Associated with Poor Fetal Outcome

by Annabelle Remoué 1,*, Yurina Suazo 1, Marie Uguen 1, Arnaud Uguen 1,2, Pascale Marcorelles 1,3 and Claire de Moreuil 4,5
Reviewer 1:
Reviewer 2: Anonymous
Submission received: 21 December 2022 / Revised: 6 January 2023 / Accepted: 7 February 2023 / Published: 9 February 2023
(This article belongs to the Special Issue Placentology)

Round 1

Reviewer 1 Report

Dear Authors,

The subject addressed in the article is interesting from the perspective of the Sars-Cov-2 pandemic. The organic or functional changes of the infection at the level of internal organs allow us to evaluate the appropriate therapeutic measures to control this viral infection.

The Introduction chapter is well done and in accordance with the subject of the article.

I think that the Material and Method Chapter has big problems. First of all, it is not clear when this study was carried out. It is mentioned by the authors that the period would be: "between January 2020 and August 2021, we collected the cases associated..." but in the Results Chapter data from another period are presented: placentas analyzed in our department from January 2002 to June 2012 ". If these data want to be the control group, then it is mandatory to present the study design as well as the inclusion or exclusion criteria.

The antibodies used for IHC are listed, but the results show images from the IHC reaction for SARS-Cov-2 antibody (Fig. 4). This marker is not presented in the Method chapter.

The IHC process is briefly presented despite that the results and conclusions of the study are based on this technique.

Table no. 1 shows some IHC evaluations using a system with +/++/+++ without presenting what it represents and what the inclusion criteria are.

In the results, the authors mention: "Delta variant, which is the SARS-CoV-2 variant biologically confirmed in the second case". What are the other two virus variants of cases 1 and 3?

Data are presented in the subsection "Lesions association among placentas before the emergence of SARS-CoV-2 virus" from: "8,857 placentas analyzed" without performing a statistical analysis but only a percentage one. The data presented in this control group must have a statistical value, not a percentage one.

From this point of view, the Conclusions can present BIAS.

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

Dear authors,

your paper is interesting, accurate and well written

the presentation of cases nice and complete

i have minor revisions to suggest

a) you've presented really nice images about histology I would like to ask you to better describe and highlight within the same images the areas where the reader must focus to identify the landmarks for the placentitis triad maybe with some circle aiming to let a reader (non expert in pathological examination) understand what to look at

2) I would like you to mention within the discussion that the three element of the placentas triad have been described in case of stillbirth for many reason (read and cite 10.36129/jog.2022.20) but of course no one of such cases due to a specific reason presented with all three at the same time as it has been documented in your  COVID cases

otherwise great job

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

Minor spell check required

Back to TopTop